Xu Y - Search Results

1

Molecular subtypes of ischemic heart disease based on circadian rhythm.

Zhou Z, Zhang G, Wang Z, Xu Y, Qin H, Zhang H, Zhang P, Li Z, Xu S, Tan X, Zeng Y, Yu F, Zhu S, Chang L, Zheng Y, Han X. Zhou Z, et al. Among authors: xu s, xu y. Sci Rep. 2024 Jun 19;14(1):14155. doi: 10.1038/s41598-024-65236-5. Sci Rep. 2024. PMID: 38898215 Free PMC article.

2

Omics-based molecular classifications empowering in precision oncology.

Zhou Z, Lin T, Chen S, Zhang G, Xu Y, Zou H, Zhou A, Zhang Y, Weng S, Han X, Liu Z. Zhou Z, et al. Among authors: xu y. Cell Oncol (Dordr). 2024 Jun;47(3):759-777. doi: 10.1007/s13402-023-00912-8. Epub 2024 Jan 31. Cell Oncol (Dordr). 2024. PMID: 38294647 Review.

3

Liu Z, Xu Y, Wang Y, Weng S, Xu H, Ren Y, Guo C, Liu L, Zhang Z, Han X. Liu Z, et al. Among authors: xu h, xu y. Imeta. 2023 Jul 16;2(3):e127. doi: 10.1002/imt2.127. eCollection 2023 Aug. Imeta. 2023. PMID: 38867932 Free PMC article.

4

The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?

Zhou Z, Zhang G, Xu Y, Yang S, Wang J, Li Z, Peng F, Lu Q. Zhou Z, et al. Among authors: xu y. Cancer Lett. 2024 Aug 10;597:217083. doi: 10.1016/j.canlet.2024.217083. Epub 2024 Jun 24. Cancer Lett. 2024. PMID: 38925363 Review.

5

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination.

Zhou Z, Mai Y, Zhang G, Wang Y, Sun P, Jing Z, Li Z, Xu Y, Han B, Liu J. Zhou Z, et al. Among authors: xu y. Cancer Lett. 2024 Aug 28;598:217079. doi: 10.1016/j.canlet.2024.217079. Epub 2024 Jun 25. Cancer Lett. 2024. PMID: 38936505 Review.

6

AI hybrid survival assessment for advanced heart failure patients with renal dysfunction.

Zhang G, Wang Z, Tong Z, Qin Z, Su C, Li D, Xu S, Li K, Zhou Z, Xu Y, Zhang S, Wu R, Li T, Zheng Y, Zhang J, Cheng K, Tang J. Zhang G, et al. Among authors: xu s, xu y. Nat Commun. 2024 Aug 8;15(1):6756. doi: 10.1038/s41467-024-50415-9. Nat Commun. 2024. PMID: 39117613 Free PMC article.

7

Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatment.

Zhou Z, Zhang R, Zhang Y, Xu Y, Wang R, Chen S, Lv Y, Chen Y, Ren Y, Luo P, Cheng Q, Xu H, Weng S, Zuo A, Ba Y, Liu S, Han X, Liu Z. Zhou Z, et al. Among authors: xu h, xu y. Cancer Lett. 2024 Nov 1;604:217273. doi: 10.1016/j.canlet.2024.217273. Epub 2024 Sep 19. Cancer Lett. 2024. PMID: 39306230 Review.

8

Associations Between Cardiovascular Health (Life's Essential 8) and Mental Disorders.

Xu Y, Ning W, Zhang Y, Ba Y, Liu H, Liu L, Wang L, Guo C, Xu H, Weng S, Zhou Z, Cai Z, Ma H, Zhang G, Jia Y, Han X. Xu Y, et al. Among authors: xu h. Clin Cardiol. 2024 Sep;47(9):e70019. doi: 10.1002/clc.70019. Clin Cardiol. 2024. PMID: 39314085 Free PMC article.

9

Associations between magnesium depletion score and depression among individuals aged 20 to 60 years.

Cai Z, She J, Liu X, Li R, Guo S, Han Z, Zhou J, Zhang H, Xu Y, Zhang G, Zhou Z, Guo X, Wu S. Cai Z, et al. Among authors: xu y. J Trace Elem Med Biol. 2024 Oct 9;86:127543. doi: 10.1016/j.jtemb.2024.127543. Online ahead of print. J Trace Elem Med Biol. 2024. PMID: 39406123

10

Targeting immunosenescence for improved tumor immunotherapy.

Liu Z, Zuo L, Zhou Z, Liu S, Ba Y, Zuo A, Ren Y, Zhang C, Chen Y, Ma H, Xu Y, Luo P, Cheng Q, Xu H, Zhang Y, Weng S, Han X. Liu Z, et al. Among authors: xu h, xu y. MedComm (2020). 2024 Oct 28;5(11):e777. doi: 10.1002/mco2.777. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39473905 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71,992 results

Search Page

Filters